Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Stretegic PRs

Stretegic PRs

posted on Dec 10, 2007 04:46AM

Flash back to a couple post of mine from the last several weeks.

1) PDS being a third party and private company has no requirement to report signings, therefore I believe many signings are complete and just waiting to be released at the most opportune time. You know these deals are not done in a day. I imagine they take weeks to workout. I am predicting we will continue to see the signings accelerate and at some point expect multiple licences to be announced in the same PR.

2) The final settlement amount will likely be left out of the PR once the litigation concludes. The company may choose to anounce the sum of all those new MMP purchases including the J3 without providing specifics of any individual deal. This would be a great opportunity to provide the investors a way to back into the numbers.

I believe TPL and PTSC will continue to withdraw deals from their PDS "completed deal" bank account until the J3 break. Coming soon daily PRs leading up to settlement.

Share
New Message
Please login to post a reply